SAN DIEGO, Jan. 23, 2018 /PRNewswire/ — Evofem Biosciences, Inc., (NASDAQ: EVFM), a clinical-stage specialty biopharmaceutical company focused on the development and commercialization of women’s healthcare products, today announced enrollment of the first patient in a Phase 2b/3 clinical…